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ABSTRACT Real-time imaging is required to guideminimally invasive catheter-based cardiac interventions.
While transesophageal echocardiography allows for high-quality visualization of cardiac anatomy, X-ray
fluoroscopy provides excellent visualization of devices. We have developed a novel image fusion system that
allows real-time integration of 3-D echocardiography and the X-ray fluoroscopy. The system was validated
in the following two stages: 1) preclinical to determine function and validate accuracy; and 2) in the clinical
setting to assess clinical workflow feasibility and determine overall system accuracy. In the preclinical phase,
the system was assessed using both phantom and porcine experimental studies. Median 2-D projection errors
of 4.5 and 3.3 mm were found for the phantom and porcine studies, respectively. The clinical phase focused
on extending the use of the system to interventions in patients undergoing either atrial fibrillation catheter
ablation (CA) or transcatheter aortic valve implantation (TAVI). Eleven patients were studied with nine in
the CA group and two in the TAVI group. Successful real-time view synchronization was achieved in all
cases with a calculated median distance error of 2.2 mm in the CA group and 3.4 mm in the TAVI group.
A standard clinical workflow was established using the image fusion system. These pilot data confirm the
technical feasibility of accurate real-time echo-fluoroscopic image overlay in clinical practice, which may be
a useful adjunct for real-time guidance during interventional cardiac procedures.
INDEX TERMS Cardiac interventional guidance, image fusion, X-ray fluoroscopy, 3D ultrasound, clinical
evaluation.
I. INTRODUCTION
Cardiac anatomical heterogeneity amongst patients (e.g. left
atrial (LA) pulmonary vein (PV) anatomy, atrial septal defect
(ASD) variations) can pose a challenge when performing
minimally-invasive procedures [1]. The accuracy of navi-
gation during cardiac procedures is limited in part by this
patient-to-patient variability and in part by the operator’s
ability to manipulate the catheter/guide wire manually to
the intended intracardiac location. Precision, safety and a
successful procedure hinge around better appreciation of
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structural anatomy and the relationship between catheters,
guide wires and anatomical structures.
Most interventional devices are designed to be X-ray vis-
ible and can be seen throughout the part of their length that
lies in the X-ray field of view (FOV). Two-dimensional (2D)
X-ray imaging is the dominant imaging modality for guiding
cardiac interventions. Typically, imaging can be performed at
high frame rates (up to 30 frames per second) and therefore
the cardiac motion and the motion of interventional devices
do not cause significant motion artefacts in the acquired
images.
In addition to X-ray, pre-procedural imaging of patients
undergoing cardiac interventions is becoming routine and
plays an important part in patient management. Imaging
modalities such as computerised tomography (CT), magnetic
resonance imaging (MRI) and three-dimensional (3D) rota-
tional X-ray angiography (RXA) or C-armCT have been inte-
grated into the cardiac catheterisation laboratory in a variety
of ways [2]–[5], with successful clinical cases reported in
the literature. This is especially common for cardiac electro-
physiology procedures where pre-procedural images can be
combined with electroanatomical mapping systems such as
Ensite (St. Jude Medical) and CARTO (Biosense Webster).
These approaches have been shown to reduce procedure time
and radiation dose, and to improve outcome for some types of
procedures [6], [7]. However, pre-procedural imaging repre-
sents a static roadmap image of the heart and cannot monitor
the cardiac intervention in real-time. This can be important
since tissue deformations do occur due to the presence of
interventional devices and delivered treatments [8]. Further-
more, elaborate techniques are required to compensate the
static roadmaps for the contractile and respiratory motion of
the heart [9].
In contrast to the relatively slow data acquisition of MRI
and CT, 3D echocardiography is a real-time imagingmodality
which is increasingly performed during cardiac interven-
tions. This technique visualises not only the relevant cardiac
structures but also the interventional devices and delivery
systems. Furthermore, 3D transesophageal echocardiogra-
phy (TEE) confers improved spatial and temporal resolution
of the cardiac anatomy. 3D TEE is now routinely used
in a variety of cardiac interventional procedures includ-
ing structural heart disease: with device closures, valvular
heart disease: with mitral annulus resizing, mitral annu-
lus repair, transcatheter aortic valve implantations (TAVI);
and in electrophysiology with trans-septal puncture guid-
ance and percutaneous left atrial appendage device closures
[10]–[12]. More recently, intracardiac echocardiography
(ICE) has been used to enable real time visualisation of
intracardiac chambers and adjacent structures and facilitate
precise guidance of catheter based procedures [13]. However
this imaging modality confers a smaller FOV in comparison
to TEE, requires an additional femoral puncture and has cost
implications with each ICE catheter being non-reuseable in
Europe and being reusable only a few times in the United
States.
Real-time 3D TEE [14] is presently used in combination
with X-ray fluoroscopy and is particularly useful in defining
location and morphology of the target cardiac structure and
anatomical relation to neighbouring landmarks. Whilst 3D
TEE allows for high quality visualisation of cardiac anatomy,
there is limited visualisation of interventional devices due
to echo artefacts. X-ray has the potential to overcome the
limitations of 3D TEE by assisting in the optimum FOV
selection for the 3D ultrasound and allowing a clearer defini-
tion of the interventional device. Procedural guidance is thus
dependent on visual information obtained from two separate
screens showing the 3D TEE and X-ray fluoroscopy. This
approach lacks the precise anatomical relationship between
the device and the cardiac structure of interest. In addition,
continued X-ray fluoroscopy during device positioning and
deployment exposes patients, especially paediatric patients
with congenital defects, to ionising radiation which carries
a significant risk [15], [16]. A possible solution to this is
integration of the real-time 3D TEE and X-ray fluoroscopy
to improve device to tissue spatial orientation.
3D ultrasound and X-ray registration is a relatively new
research topic. Previous studies have used modified hardware
to track the probe. One approach focused on the registration of
transthoracic echocardiography (TTE) and X-ray [17] using
a mechanical tracking device. Based on the same principle,
Jain et al. [18] reported a method to register TEE volumes
with X-ray by using an electromagnetic (EM) tracking sys-
tem. Alternatively, a fiducial-based approach can be used
to track small, X-ray visible markers attached to the TEE
device [19].
We have previously developed an accurate and robust
image-based algorithm for registration of 3D TEE and
X-ray fluoroscopy [20]. This image-based approach requires
nomodification of the existing hardware and so is more suited
to clinical translation. In the current paper, we develop this
further into a real-time clinical system to carry out the image
fusion. To our knowledge, this is the first real-time clinical
platform developed using this concept. While we have pre-
viously demonstrated successful registration of static clinical
images in [20], we now perform a more extensive validation
using the real-time implementation with sequences of images
over time. We perform pre-clinical experiments to validate
the platform and clinical feasibility experiments to establish
a workflow for the system and to measure clinical accuracy.
II. METHODS
A. SYSTEM OVERVIEW
Fig. 1 gives an overview of the prototype clinical system in
which live X-ray and 3D echo are integrated to obtain the
hybrid view. The hardware comprises a Philips Allura Xper
FD10 C-arm X-ray system and a Philips iE33 3D ultrasound
systemwith an X7-2t 3D TEE probe. Data is streamed in real-
time from each image source to a PC running the fusion and
visualisation software. The software displays the live X-ray
images overlaid with a projection of the live 3D echo volume.
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FIGURE 1. Both the X-ray fluoroscopic image and echocardiography
image are acquired separately and streamed into the visualisation
platform that allows for the real-time integration of the two modalities.
The two modalities are registered using our previously
described method [20]. In brief, this uses a previously
acquired nano-CT image of the TEE probe which is reg-
istered to the projection image of the probe in the X-ray.
The registration algorithm involves simulating the X-ray
projection process to generate projections of the 3D probe
image, called digitally reconstructed radiographs (DRRs).
Using these images, the algorithm iteratively adjusts the posi-
tion and orientation of the 3D probe image to obtain the
best match between its DRR and the X-ray projection. Fig. 2
shows a typical X-ray view, the probemodel and a registration
of the two. The reader is referred to [20] for further details of
the algorithm.
In the clinical prototype, this iterative process is initialised
manually to approximately the correct position and ori-
entation before running the automatic 3D-2D registration.
Following the initial alignment, the automatic registration
is repeatedly rerun on the updating X-ray images to track
changes in the probe position due to cardiac and respira-
tory motion. This registration is GPU-accelerated (Graphical
Processing Unit, NVIDIA GeForce 8800GTX) and updates
in this way at a rate of 1–2 Hz, sufficient for near-real-
time tracking of the probe position. This is a significant
improvement on our previous implementation [20] in which
an equivalent setup required an average of 8 s per registration.
B. STUDY OVERVIEW
The protocol was divided into 2 phases. The pre-clinical
phase involved use of the system for data acquisition from
a phantom model and during a porcine experimental study.
The second, clinical phase involved use of the system for
data acquisition during catheter ablation (CA) in 9 patients
and TAVI in 2 patients following approval from the Local
Research Ethics Committee.
C. PRE-CLINICAL STUDY (STAGE 1)
1) PHANTOM MODEL
In Stage 1, the prototype image-based TEE probe localisation
algorithm was validated using a phantom model. The phan-
FIGURE 2. Automatic overlay registration. (a) TEE probe model from a nano-CT scan of the probe head. (b) X-ray image with the projection of the TEE probe
clearly visible. This example is from an AF ablation case. (c) Probe model registered to the X-ray by automatic 3D-2D registration.
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FIGURE 3. (a)–(c) Phantom model experimental overlay of fluoroscopic and echocardiographic images. Errors were measured between automatically defined
points on straight line models of the crossed wires. (d)–(f) Porcine experimental study overlay. Errors are measured as the shortest distance from automatically
defined points on the echo catheter image to a spline model of the X-ray catheter.
tom comprised a water tank in which two wires were sus-
pended forming a cross. This was imaged by the TEE probe
with the ultrasound machine in full volume mode. Corre-
sponding X-ray images were acquired at two different C-arm
positions (RAO 54 and RAO 24 views) each at high and low
dose (4 X-rays in total). From these 4 sequences, 12 overlay
views were generated using 3 different images from each
sequence. Alignment errors were measured on each overlay
view.
Errors were measured between corresponding points on the
X-ray and echo projection images of the crossed wires. These
error measurement points were defined by manually fitting
straight-line models to the projected images of the crossed
wires in the two imagingmodalities. The crossing points were
then detected automatically from these fitted lines and cor-
responding measurement points were automatically defined
in fixed steps along the lines from the crossing point. This
provided up to 13 measurements per overlay view (minimum
10 where the crossing point was near the edge of the view).
Fig. 3(a)–(c) shows an example of this. 2D projection errors
were calculated between corresponding points and averaged
to give an overall alignment error, e, for the overlay view as
follows
e = 1
N
N∑
i=1
∣∣Pi,xray − Pi,echo∣∣ Dsource→targetDsource→detector (1)
where N is the number of measurements, and Pi,xray and
Pi,echo are the locations of corresponding points i in the over-
lay view. Dsource→target and Dsource→detector scale the errors
measured in the magnified X-ray projection view to errors at
the patient location. The final error value is given in mm.
2) PORCINE EXPERIMENTAL STUDY
In vivo data to measure accuracy were acquired from a live
porcine experiment. Following successful trans-septal punc-
ture, a circular mapping catheter (InquiryTM OptimaTM, St.
Jude Medical Inc.) and an ablation catheter (3.5 mm irrigated
tip catheter NaviStar R© ThermoCool R©, Biosense Webster
Inc., Diamond Bar, CA, USA) were positioned within the
left atrium. Five echo volumes were acquired in full volume
mode with the probe in different positions. At each posi-
tion, between one and three X-ray sequences were recorded
(RAO 30, LAO 30 and PA positions) with high X-ray dose
setting (9 X-ray views in total). The catheters inside the
heart during the acquisition provided convenient targets for
measuring alignment errors.
Although real-time synchronised visualisation of the live
data stream was possible during the procedure, the post-
procedure analysis for this paper required that the recorded
X-ray and echo data were synchronised manually, result-
ing in only approximately synchronised sequences. Auto-
matic registrations were done at two separate frames in each
X-ray sequence (18 overlay views generated). Correspond-
ing catheters were manually defined in the echo and X-ray
views using Catmull-Rom spline curves. Equally spaced
points along the echo curve were automatically defined as
measurement points. The corresponding X-ray point was
defined as the closest point on the X-ray curve. The alignment
error for each overlay view was again taken as the average
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FIGURE 4. Clinical study to document feasibility in an AF ablation case. Real-time hybrid views were generated during the trans-septal puncture and
subsequent placement of circular mapping and ablation catheters within the left atrial chamber.
of the 2D errors between corresponding points, in the same
way as in the phantom experiments. An example of these
error measurements is given in Fig. 3(d)–(f). Average errors
were measured using between 4 and 6 point pairs per overlay
view, depending on the length of catheter visible in the echo
image. In all cases, the mapping catheter was used for the
measurements, because it was the most consistently visible
catheter over all the echo images.
D. CLINICAL STUDY (STAGE 2)
Stage 2 focused on extending the use of the software to
the clinical setting. The aim was to assess the workflow of
the platform during live clinical procedures and not to guide
the interventional procedure at this early stage. The operators
performing the procedure relied on the conventional standard
echo visualisation on one screen and the fluoroscopic image
on another. Patients studied here were candidates undergoing
an ablation for atrial fibrillation (AF) under general anes-
thesia, requiring a TEE, and patients undergoing a TAVI
procedure. During each case, X-ray and echo sequences were
acquired independently and streamed into the visualisation
software. X-ray and echo sequences were also recorded for
post-procedure analysis. During the procedure, real-time syn-
chronised visualisation of the live data streams was achieved
automatically. However, the post-procedure study for accu-
racy required that the recorded X-ray and echo sequences
were synchronised manually. The catheters used to measure
accuracy were those that were visible in the echo image at
the time of acquisition. This varied depending on the stage of
the procedure, but was often only one device at a time. For the
electrophysiology studies, catheter sheaths were used for
error measurement, as well as mapping and ablation catheters
(see Fig. 4 for example images). For the TAVI procedures, the
guide wire was used for error measurement in both sequences
(Fig. 5).
1) CLINICAL ELECTROPHYSIOLOGY STUDY
Following establishing conscious sedation and peripheral
access, a 6F decapolar catheter was placed in the coro-
nary sinus (as a reference during electroanatomic mapping
and to enable LA pacing) and the XFr NIH catheter was
placed within the superior vena cava (Fig. 4(a)). Simul-
taneously, a TEE probe (echo frequency 5–8 MHz) was
advanced to study the left atrium and exclude a left atrial
appendage clot. The probe was then rotated to visualise
the interatrial septum, assessing for possible patent foramen
ovale and establishing the most suitable site for trans-septal
puncture (Fig. 4(b)). Once established, the probe was held
still in place and the image obtained was overlaid onto the
fluoroscopy.
Two trans-septal punctures weremade and access to the left
atrium was obtained using 8.5F non-deflectable long sheaths,
(St. JudeMedical Inc., St. Paul,MN, USA) (Fig. 4(c) and (d)).
Following the first trans-septal puncture, intravenous heparin
was administered to achieve an activated clotting time of
between 300 and 400 seconds. A 3D geometry of the left
atrium was created using either NavXTM (St. Jude Medical
Inc., St. Paul, MN, USA) or CARTO XP (Biosense Webster
Inc., Diamond Bar, CA, USA). A circular mapping catheter
(InquiryTM OptimaTM, St. JudeMedical Inc.) was then placed
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FIGURE 5. Clinical study to document feasibility in a TAVI case. Real-time hybrid views were generated during
the placement of the Edwards core valve within the native aortic valve followed by the deployment of the
prosthetic valve.
in each pulmonary vein in turn while the corresponding
LA-PV antrum was targeted with wide area circumferential
ablation (Fig. 4(e) and (f)).
2) TAVI
The procedure was performed under general anesthesia in the
catheterisation laboratory under strict aseptic conditions, by
a team comprising interventional and imaging cardiologists,
cardiac surgeons and anesthetists. The TEE probe was posi-
tioned to view the left ventricular outflow tract and ascending
aorta, aortic valve and left ventricle.
The stenosed aortic valve was crossed with a hydrophilic
wire (Terumo Medical, Somerset) supported by an AL1 5F
diagnostic catheter (Fig. 5(a) and (b)). A pigtail catheter
was then advanced into the LV whilst simultaneous pressure
recordings (LV/aorta) were performed. Over the pigtail, a
super stiff 260-cm long wire, with a floppy tip of only 1 cm
(Amplatz ST1, Amplatz Cook, Indiana) was inserted. An
18F sheath was then advanced carefully over the Amplatz
catheter with a subsequent two-stage process: firstly, as the
tip of the dilator entered the aorta, it was stabilised and
the sheath was advanced over it until it rested just inside
the aortic lumen. Next, over the stiff wire a Nucleus bal-
loon catheter (NuMED, NY) was advanced and valvuloplasty
was successfully performed. Following this, the CoreValve
prosthesis itself was advanced through the sheath and across
the aortic valve (Fig. 5(c)) and successfully deployed in its
correct position in the patient (Fig. 5(d)). Repeated contrast
injections performed through the aortic root positioned pigtail
confirmed satisfactory positioning.
E. STATISTICAL ANALYSIS
Summaries for continuous variables are expressed as median
and interquartile range (IQR) and mean ± SD. A student’s
t-test was used to determine the differences between groups.
A p value of less than 0.05 was considered statistically sig-
nificant. Statistical analyses were performed using Matlab
(R2010b).
III. RESULT
A. VALIDATION OF THE SYSTEM PLATFORM IN THE
PRECLINICAL STUDY
1) OVERLAY ALIGNMENT ACCURACY
In the phantom model, 12 synchronised echo-fluoro image
pairs were overlaid. On each hybrid image, a mean of 11.5
measurements (range 10–13) between corresponding points
on the crossed wires were made to assess the 2D pro-
jection error. From a total of 138 error measurements, a
median alignment error of 4.5 mm (IQR 3.0–5.9 mm) was
calculated.
In the porcine experimental study, 18 synchronised echo-
fluoro image pairs were overlaid. Each had between 4 and 6
projection error measurements made between corresponding
points on the mapping catheter (83 measurements in total).
A median alignment error of 3.3 mm (IQR 2.6–4.9 mm) was
calculated. Fig. 6 shows the two datasets as boxplots.
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FIGURE 6. The box plots display the overall alignment error
measurements evaluated in the phantom model and the porcine
experimental study.
B. WORKFLOW ASSESSMENT OF THE PLATFORM IN THE
CLINICAL SETTING
1) PATIENT POPULATION AND CLINICAL SYNOPSIS
As shown in Table 1, a total of 11 patients were stud-
ied. The 9 patients with symptomatic drug-refractory AF
(paroxysmal/persistent) undergoing catheter ablation had the
following characteristics: age, 59.2±8 years; male/female,
6/3; weight, 95.6±18.2 kg (range 64–110 kg); mean dura-
tion of AF, 5.4±3.8 years (range 1–11 years); and left ven-
tricular ejection fraction, 50±10% (range, 40–70%). The
2 TAVI patients were both male aged 89±1.4 years, weight
82.5±5.6 kg (range 80–90 kg) with moderate renal func-
tion and an ejection fraction of approximately 35%. All
11 patients underwent successful uncomplicated procedures.
In the AF group, all 4 pulmonary veins were isolated
and in the TAVI group the Corevalve (Edwards Corevalve)
prosthesis was deployed with good positioning confirmed
on echo.
2) REAL-TIME HYBRID X-RAY FLUOROSCOPY AND 3D ECHO
VISUALISATION IN PATIENTS
Successful real-time integration was achieved in all
11 clinical cases. Figs. 4 and 5 show typical examples of
overlays from the catheter ablation and TAVI cases. From a
total of 124 alignment error measurements made, a median
error of 2.4 mm (IQR 1.3–3.9 mm) was achieved. In the
catheter ablation cohort (100 measurements) a median of
2.2 mm (IQR 1.3–3.4 mm) was calculated whilst among the
TAVI cohort (24 measurements) a median of 3.4 mm (IQR
1.5–4.7 mm) was achieved. Fig. 7 illustrates the individual
median errors in 11 cases. Median alignment difference
between catheter ablation and TAVI procedures was 1.2 mm
(p = 0.17).
FIGURE 7. The box-plots describe the alignment error measurements in
the clinical cases. The first nine box-plots were obtained from the AF
cases and the remaining two from TAVI cases.
TABLE 1. Patient characteristics and procedural data.
IV. DISCUSSION
This is the first study to report a platform for real-time 3D
TEE and X-ray fluoroscopy image integration evaluated in a
phantom model, porcine experimental study and in the clin-
ical setting. The main findings of this study are (1) success-
ful real-time image integration and overlay of 3D TEE and
X-ray fluoroscopy, (2) a median real-time alignment accuracy
of 4.5 mm and (3) a feasible workflow during the platform
application within the clinical setting.
The main aim of the study was to examine the feasibility
of overlaying 3D-echocardiogram volumes onto fluoroscopic
images during real-time catheter/guide wire navigation. This
platform does not involve the use of any additional tracking
devices and therefore can be easily integrated into the current
workflow of the catheter laboratory. The fundamental utility
of this combination is the ability to better appreciate soft
tissue anatomy in relation to the catheter/guide wire during
navigation and device deployment.
One of the potential advantages of the hybrid echo-
fluoroscopy imaging modality is increased and more
precise control of positioning of the catheter/guide wire.
Visualisation of catheter direction in relation to the
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anatomical structures facilitates faster and more accurate
catheter movement to the intended anatomical site. Figs. 4
and 5 show typical examples of overlays from clinical cases.
An echo volume on its own can be difficult to interpret
because of its limited FOV and lack of context for the
echo coordinate system relative to the patient. Catheters and
devices tend to produce artefacts in the ultrasound data reduc-
ing the clarity of the images. In the overlay view, the echo
volume is displayed in a coordinate system that can be more
easily related to the patient. Also, the highly visible catheters
in the X-ray image help with identifying the catheters in the
echo and so can be related to the cardiac anatomy via the echo
image. During an ablation procedure, the precise location of
the catheter tip and electrodes on the mapping catheter in
relation to atrial tissue permits better targeted lesion delivery
than just visualising the catheter as a whole on fluoroscopy.
Similarly during a TAVI procedure, being able to visualise
both the native valve and the prosthesis on a single image will
facilitate delivery and deployment of the prosthetic valve.
The accuracy requirement for a clinically useful image
guidance system depends on many factors including the
patient and the type of procedure being performed [21], [22].
An accuracy of less than 5 mm is often deemed as a suitable
target for many applications and this threshold is highlighted
on the plots in Figs. 6 and 7wheremost of the errors are below
the 5 mm threshold. Based on these results, the system is
sufficiently accurate to guide catheter/guide wire navigation.
It should be noted that the location of the catheter in the echo
volume will affect the accuracy, as objects further from the
probe will have a greater misalignment due to errors in the
probe’s orientation.
The standard deviations noted within the figures are, in
part, likely to arise from some data streaming delay in the
visualisation software and, in part, time lag in X-ray regis-
tration. The largest standard deviations are due to respira-
tory motion acting on the probe, which is not immediately
compensated by the 1–2 Hz registration updates. While all
sequences encounter respiratory motion, variations in the
probe position and X-ray direction produce different scales
of potential error in each sequence. The median alignment
error difference between the TAVI and ablation procedures
(3.4 mm vs 2.2 mm) may be attributed to the rapid movement
of the guide wire/device that is located near the aortic valve
in contrast to the lasso and ablating catheter located within
the left atrium. In comparison to the phantom data, both the
porcine and clinical study had lower alignment errors. This
may be due to the error measurement techniques: full 2D
errors were measured in the phantom experiment whereas in
the porcine and clinical experiments it was only possible to
measure to the nearest point on the corresponding catheter.
Other studies on echo-fluoroscopy overlay have also found
clinically-useful accuracies. In [18], the mean error was
approximately 2.0 mm when imaging a heart phantom and
tracking the TEE probe with an electromagnetic tracking
system. More recently, Lang et al. [19] found a mean error of
approximately 1.2 mm in vivo, by tracking fiducial markers
attached to the TEE probe. These are both better than our sys-
tem’s average accuracy, but require devices to be attached to
the probe. The results therefore highlight a trade-off between
accuracy and ease of clinical integration.
In this study, we have presented a platform for real-time
hybrid X-ray fluoroscopy and 3D echo visualisation and have
successfully demonstrated a feasible workflow within the
clinical setting. We anticipate that by gaining familiarity and
confidence within this hybrid viewing system, there will be
a lesser need for repeated X-ray fluoroscopy use to estab-
lish catheter position. On-going research is actively seeking
to reduce the use of, or even replace, X-ray fluoroscopy
in cardiac interventional procedures, especially for paedi-
atrics [23]–[25]. With increased usage over time, we pre-
dict a greater reliance on echo views to assist catheter/guide
wire navigation. In the long run, this will reduce overall
fluoroscopy time and patient exposure to ionising radiation.
Ultimately, randomised comparisons of real-time hybrid
X-ray fluoroscopy and 3D echo image-guided therapy with
standard visualisation approaches are necessary to defini-
tively establish its clinical utility and translate it from an
experimental method to a clinical routine.
A. PRESENT LIMITATIONS
It is important to recognise that one of the main objectives of
this study was to assess the clinical feasibility of the proposed
method. Although all the porcine experimental and clinical
data were acquired specifically for this study, the data analysis
was performed off-line. The porcine experiment in particular
may suffer from artificially large errors due to the echo and
fluoroscopy images not being acquired simultaneously. Our
future work will focus on evaluating the accuracy of the live
system and further improving the co-registration.
In addition, our approach of measuring to the closest point
accounts for 2D in plane errors and does not necessarily
capture the complete error as there can also be misalignment
tangentially to the catheters. However, many of the catheters
were curved, which reduces the severity of this limitation.
The clinical case numbers in this study at the present time
are small. While we have established the clinical feasibility of
this system, further studies involving larger patient groups are
required to demonstrate that this novel technique translates
into reduced fluoroscopy time, reduced complications and
better overall patient outcome.
V. CONCLUSION
In this study, we have developed a clinically-integrated sys-
tem for real-time hybrid X-ray fluoroscopy and 3D echo visu-
alisation. The practicability of accurate real-time hybrid visu-
alisation was demonstrated in both a phantom model and a
porcine experimental study. The clinical series demonstrated
a feasible clinical workflow, with successful image fusion in
all cases. Further clinical validation and a randomised com-
parison between real-time hybrid echo-fluoro image-guided
therapy versus a standard visualisation approach is needed
to translate this tool into routine clinical practice, where it
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may prove useful for real-time guidance of catheterisation
interventions.
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